Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Progesterone clinical trials

The results of the WHI (Women s Health Initiative) Estrogen Plus Progesterone clinical trial revealing increased incidence of breast cancer, heart disease, stroke, and dementia are provided in J. E. Rossouw et al., JAMA 288 321-333 (2002). [Pg.383]

The Progesterone Receptor (PR) has been the target of drug discovery and development for the past few decades. Whilst PR agonists have been widely used in women s health care, PR antagonists have received relatively little utility in the clinic. Recently, steroidal agents, such as mifepristone (RU-486) and asoprisnil have shown efficacy in reducing the symptoms of uterine fibroids in clinical trials. [Pg.125]

Fig. 6 YOUDEN diagram and test kit related evaluation of ring trial results for progesterone analysis in serum conducted by the German Society of Clinical Chemistry (DGKC)... Fig. 6 YOUDEN diagram and test kit related evaluation of ring trial results for progesterone analysis in serum conducted by the German Society of Clinical Chemistry (DGKC)...
See other pages where Progesterone clinical trials is mentioned: [Pg.445]    [Pg.102]    [Pg.139]    [Pg.50]    [Pg.326]    [Pg.169]    [Pg.836]    [Pg.56]    [Pg.129]    [Pg.270]    [Pg.162]    [Pg.243]    [Pg.720]    [Pg.386]    [Pg.207]    [Pg.489]    [Pg.202]    [Pg.216]    [Pg.974]    [Pg.1414]    [Pg.150]    [Pg.241]    [Pg.605]    [Pg.2412]    [Pg.6]    [Pg.16]    [Pg.182]    [Pg.245]   
See also in sourсe #XX -- [ Pg.221 , Pg.253 ]



SEARCH



Progesteron

Progesterone

© 2024 chempedia.info